CD274 and thyrotoxicosis: During the observation period, 45 (6.1%) and 4 (17.4%) patients developed thyrotoxicosis after initiation of the PD-(L)1-Ab and PD-(L)1-Ab/TKI treatments, respectively, all of whom were diagnosed with DT based on TRAb negativity (Table 2).